In addition, we found that PLA2G2D and LPCAT2 were significantly enriched in the group of N0 vs O0 by GSEA (Figure S1B), which further validated PLA2G2D and LPCAT2 as key HHT-resistance genes in AML cells. The gene discussed is PLA2G2D; the disease is acute myeloid leukemia.